background: Progesterone-withdrawal (WP)-induced endometrial breakdown occurs in both physiological and pathological processes such as menstruation and abortion. However, the underlying mechanisms are not clearly understood. As the nuclear factor-kB (NF-kB) pathway has been proposed to play a role in endometrial breakdown, we tested this hypothesis using RU486-induced mouse menstruation-like model.
Introduction
In female reproductive physiology, endometrial breakdown is critical for menstruation, abortion and parturition. To date, the molecular mechanism responsible for endometrial breakdown has not been fully elucidated. One of the obstacles is the availability of non-human primate models. Fortunately, the mouse menstruation model provides a convenient tool to investigate the mechanisms underlying the endometrial tissue breakdown process (Finn and Pope, 1984; Xu et al., 2007) .
Progesterone withdrawal (WP) is well accepted as a trigger for the initiation of menstruation. Progesterone binds to its receptor to exert physiological actions in the reproductive organs. WP, either by stopping the hormone supply or by blocking it with a receptor antagonist such as the antiprogestin RU486, reverses a cascade of events in the network of downstream genes to inhibit progesterone effects. Among many pathways, it has been suggested that nuclear factor-kB (NF-kB) participates in regulatory processes downstream of progesterone receptor (PGR) engagement (McKay et al., 1999; Ross et al., 2010) .
NF-kB is a family of dimeric transcription factors (usually RelA/ P65:P50) involved in inflammatory and immune responses. In general, the dimer is sequestered in the cytoplasm of unstimulated cells by binding to IkB proteins, inhibitors of the kB family of proteins. The activation of NF-kB by various stimuli causes phosphorylation of IkB, followed by its ubiquitination and subsequent degradation. This process liberates the NF-kB dimer and allows its translocation from the cytoplasm into the nucleus to regulate the expression of target genes. Many inflammatory and immune mediators, such as interleukin-8, tumor necrosis factor and cyclooxygenase-2, which are all targets of NF-kB, have been confirmed to be relevant to menstruation (Sun et al., 2004; Peluffo et al., 2009; Catalano et al., 2011; Maybin et al., 2011) . Furthermore, accumulating evidence indicates that the process of menstruation is associated with inflammatory-like immune reactions Kelly et al., 2001; Salamonsen et al., 2002) . King et al. (2001) previously suggested that the NF-kB signal is activated in the endometrium during the perimenstrual phase. Isolated stromal cells under conditions mimicking progesterone and estradiol (E 2 ) withdrawal display activated NF-kB (Sugino et al., 2004) . In our preliminary studies (unpublished observations), we used a Signal Transduction Pathway Finder Gene Array (Super Array Bioscience, USA) to analyze the course of events following RU486 treatment. The results of those gene array experiments revealed distinct changes in the expression of a panel of genes related to the NF-kB transduction pathway during menstrual-like bleeding in the mouse model. The data suggested that NF-kB is a downstream component after PGR in the potential signaling pathways.
During menstruation, matrix metalloproteinases (MMPs) have been identified as the major effectors in the breakdown (Marbaix et al., 1996) and subsequent remodeling (Gaide et al., 2009; Russo et al., 2009 ) of endometrial tissues. WP can rapidly induce the expression of multiple MMPs either in vivo or in vitro (Marbaix et al., 1996; Salamonsen et al., 1997; Lockwood et al., 1998; Keller et al., 2000) . Among these MMPs, MMP9 (also known as gelatinase B) preferentially degrades basement membrane components (Cohen et al., 2006) . Moreover, among the MMP superfamily, MMP9 is the only one whose genetic deletion can cause subfertility in mice, Thus, MMP9 plays a critical role in reproduction (Dubois et al., 2000) . However, in reported studies of the menstrual cycle, the endometrial MMP9 expression pattern is highly complex. MMP9 is widely expressed in various cell types, including stromal cells, epithelial glandular, invading leucocytes and arteriolar walls; other MMPs are apparently expressed in one specific cell type (Rodgers et al., 1993 (Rodgers et al., , 1994 . Therefore, the mechanisms of the regulation of MMP9 may be more complicated than for other MMPs. A study showed that expressions of MMPs were partly regulated by different transcription factors, including NF-kB in macrophage cells (Vincenti and Brinckerhoff, 2007) . Inhibiting NF-kB can prevent the up-regulation of MMP1, MMP3 and MMP9 in vascular smooth muscle cells (Bond et al., 2001) . MMP9 is one of the target genes of NF-kB in some cell types such as mouse macrophage cells that lipopolysaccharide (LPS) induced production of MMP9 requires the activation of in a mouse macrophage cell line, while inhibition of NF-kB represses LPS-stimulated MMP9 activity in amnion and choriodecidual explants (Rhee et al., 2007; Lappas et al., 2003) . Furthermore, the effect of olive oil extracts and individual compounds on MMP9 was shown to be due to impaired NF-kB signaling in human acute monocytic leukemia cell line cells (Dell'Agli et al., 2010). Based on these observations, we hypothesized that NF-kB regulates the expression of MMP9 during the process of tissue breakdown.
Although the modulation of MMP9 by NF-kB is critical in many physiological and pathological conditions, the interaction and the involvement of these molecules in menstruation have not been clearly illustrated. In the present study, we provide evidence that activation of the NF-kB pathway following RU486 treatment induced the expression of its downstream target genes such as MMP9 in stromal cells and binding to the MMP9 gene promoter to facilitate endometrial tissue breakdown in a mouse menstruation-like model.
Materials and Methods

Animal groups and tissue collection
The studies were carried out in accordance with the principles and procedures of the Animal Ethics Committee of the National Research Institute for Family Planning. Virgin female C57BL/6J mice (8-9 weeks old) were purchased from the Institute of Laboratory Animal Services CAM-S&PUMC. Mice were bred in controlled light (lights on from 0800 to 2000 h) and temperature (21 + 18C) conditions. The procedures for establishing the menstruation model are outlined in Fig. 1 and were slightly modified from the details described previously (Brasted et al., 2003; Xu et al., 2007) .
Briefly, mice were ovariectomized and allowed to recover for 1 week. They were then given steroid hormones and progesterone implants at the determined time points shown in Fig. 1 . Fifteen microliters of Arachis oil was injected into the uterine lumen to induce decidualization. Forty-eight hours later, the mice were treated with RU486 (120 mg/kg, Beijing Zizhu Pharmaceutical Co., Ltd., Beijing, China) given by intragastric (i.a.) administration (designated as 0 h). The mice were then sacrificed by cervical dislocation at 0, 8, 12, 16 and 24 h, and their uterine horns were harvested. Part of each horn was fixed in 4% paraformaldehyde solution or snap frozen in liquid nitrogen and stored at 2808C until analysis.
Immunohistochemistry
Specificity dilutions and commercial sources of primary antibody are shown in Table I . All incubations were at room temperature, unless otherwise stated. Briefly, uterine cross sections were deparaffinized and rehydrated, followed by an antigen retrieval procedure (citrate buffer, pH 6.0; 958C heat for 15 min). Endogenous hydrogen peroxidase activity was quenched using 3% H 2 O 2 in Tris-buffered saline (TBS) for 10 min. Non-specific binding was prevented by blocking in TBS with 5% goat serum (Invitrogen, Carlsbad, CA, USA) and 1% bovine serum albumin (BSA) for 2 h. Sections were incubated with primary antibodies diluted in 1% BSA in TBS overnight 
Western blotting
Cytoplasmic and nuclear extracts of the uterine tissues were prepared according to the instructions of the nuclear and cytoplasmic extraction reagent kit (Thermo Scientific, Rockford, IL, USA) with phosphatase inhibitor (Roche, Mannheim, Germany) and protease inhibitor (Merck KGaA, Frankfurter Str., Darmstadt, Germany). Total proteins for detecting MMP9 were extracted using RIPA lysis buffer (Beyotime, JiangSu, China) and protease inhibitor (Merck). After transfer, the membrane was blocked for 1 h with TBST [50 mM Tris -HCl, 150 mM NaCl and 0.1% (v/v) Tween-20] containing 5% (w/v) non-fat dried milk and then incubated with specific primary antibodies overnight at 48C. Membranes were rinsed in TBST and then incubated with HRP-conjugated antibody at 1:10000 dilution for 1 h. Proteins in blots were visualized with an enhanced chemiluminescence system (Transgen, Beijing, China) and X-ray film . Specificity, dilutions and commercial sources of primary antibodies are shown in Table I . All incubations were at room temperature, unless otherwise stated.
Cell culture experiments
Isolation and culture of murine endometrial stromal cells and immunofluorescence
The mouse endometrial stromal cells were prepared from 6 to 10 uteri collected at 48 h after artificial decidual stimulation, as described previously with minor modifications (Wegner and Carson, 1992) . The stromal cells were resuspended in basal medium: Dulbecco's modified Eagle's medium/F12 without phenol red (Sigma-Aldrich, St-Louis, MO, USA) supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin, 10% charcoal-stripped fetal bovine serum (FBS) (Thermo Scientific), 1 mM medroxyprogesterone acetate (MPA) and 10 nM 17-b E 2 (Sigma-Aldrich). Cell cultures were maintained at 378C in humidified air with 5% CO 2 . An anti-vimentin rat monoantibody and an anti-prolactin goat polyantibody were used to assess the purity of stromal cells and degree of decidualization, respectively. MG-132, as an inhibitor of NF-kB, was used to block its signaling in cultured cells (Awasthi et al., 2008; Huang et al., 2009) . All incubations were at room temperature, unless otherwise stated. After culture for 18-30 h, the cells were subjected to the following treatments: A, basal medium; B, basal medium + 1 mM RU486; C, basal medium + 1 mM RU486 + 2.5 mM MG-132 (Enzo, Plymouth Meeting, PA, USA). The expression of MMP9 in cultured cells was determined within 24 h. Meanwhile, isolated stromal cells were grown on poly-L-lysine-coated coverslips. After the cells were treated with conditioned medium B (basal medium + 1 mM RU486) to mimic WP for 16 h, the cells were fixed with 4% formaldehyde for 15 min and permeabilized in 0.3% Triton X-100 for 10 min. They were then incubated with primary antibody overnight at 48C and stained with fluorochrome-conjugated secondary antibody for 20 min, and the signals were visualized by fluorescence microscopy using a NIKON TS100 inverted microscope (Nikon, Melville, NY, USA) with a Q Imaging digital camera. Specificities, dilutions and commercial sources of primary antibodies are also shown in Table I .
Human endometrial stromal cells
Endometrial tissues for culture were obtained from hysterectomy in patients (n ¼ 5) at 38-to 45-year old, with regular menstrual cycles and histologically diagnosed as late proliferative or early secretory phase. The stromal cells were prepared and cultured as described previously (Laird et al., 1997; Sugino et al., 2004) . The cells were distributed into six-well tissue culture grade plates (Corning) after three passages. Decidualization was conducted by incubating cells in a medium containing 2% charcoal-stripped FBS, antibiotics, 100 nM MPA and 10 nM E 2 for 11 days in vitro. Decidualization of all cells was confirmed by a radioimmunoassay for prolactin (Cangyuan Reide Biotechnology Co., Ltd., Beijing, China) in a culture medium. Then the cells were subjected to the following treatments: A, basal medium; B, basal medium + 1 mM RU486; C, basal medium + 1 mM RU486 + 2.5 mM MG-132 (Enzo). Culture medium was renewed every 2 days. The expression of MMP9 in cultured cells was examined within 6 days.
Real-time PCR
Total RNA from frozen uteri and cultured stromal cells was extracted using Trizol (Invitrogen) according to the manufacturer's instructions. cDNA was synthesized with 2 mg total RNA using reverse transcriptase (Takara Bio, Otsu, Japan). The reverse transcription was performed with oligo (dT) primers (25 pmol, Takara) and random primers (50 pmol, TaKaRa) by following the manufacturer's protocols. Real-time PCR was performed on a StepOne TM Real-time PCR System (ABI, Carlsbad, CA, USA) using SYBR w Premix Ex Taq TM II (Takara Bio) and specific primers for each gene. b-Actin was used as the internal control. The thermal cycling conditions were an initial activation cycle at 958C for 5 min, followed by 40 cycles of denaturation (958C for 10 s), annealing and amplification (608C for 31 s). All primer sequences are shown in Table II . All reactions were performed in triplicate. Relative quantification was achieved using the formula 2 −DDCt , where DDC t is the difference of the calibrated C t value between test and control.
MMP activity assays
Gelatin zymography was used to detect MMP9 activity in samples as described by Leber and Balkwill (1997) brief, proteins were separated by SDS -PAGE on a 10% acrylamide gel containing 0.1% gelatin (Sigma-Aldrich) under non-reducing conditions. After two washes in renaturing buffer (2.5% Triton X-100, 50 mmol/l Tris -HCl in distilled water, pH 7.6) with gentle agitation for 40 min at room temperature, the gels were equilibrated and incubated in developing buffer (50 mM Tris, 0.2 M NaCl, 5 mM CaCl 2 and 0.2% Brij 35, pH 7.6) with gentle agitation for at least 42 h at 378C. Finally, the gels were stained with Coomassie Blue R-250.
Chromatin immunoprecipitation assays
Chromatin immunoprecipitation (ChIP) assays were performed using a ChIP assay kit (Cell Signaling Technology) following the manufacturer's instructions and previous reports (Kwon et al., 2008; Bansal et al., 2009) . Briefly, isolated chromatins from the frozen uterine tissues were immunoprecipitated using a p65 antibody (10 mg/IP, ab7970, Abcam). A rabbit histone H3 monoantibody (positive control, 1 mg/IP) and normal rabbit immunoglobulin G (negative control, 1 mg/IP) were also used as controls. The immunoprecipitated DNA was detected using real-time PCR. Data were analyzed with the Percent Input Method: 2(C t of the 2% Input Sample2C t of the IP Sample) × 2% ¼ Percent Total Input. The primers used for the MMP9 promoter are listed in Table II .
In vivo NF-kB inhibitor treatment
In this study, we selected pyrrolidine dithiocarbamate (PDTC) (SigmaAldrich), an inhibitor of NF-kB. The dose of PDTC was determined based on previous studies (Djurkovic-Djakovic et al., 2005; Gu et al., 2009) . Female mice were given either saline (n ¼ 12) or PDTC (dissolved with saline, 250 mg/kg) (n ¼ 25) by i.p. injection, followed by RU486 administration 1 h later. Twenty-four hours later after RU administration, the uteri were harvested. Representative segments of the uteri were prepared for histological assessment to determine the effect of the inhibitor. The evaluation of breakdown efficacy was performed using a Leica microscope with the associated software (Leica Laser Microdissection V6.3). The whole decidual area and breakdown area were outlined using the select tool of the program. The extent of tissue breakdown was presented as the percentage of breakdown area to the total decidual zone area. Vaginal smears and morphological changes in the model were also examined. The horns without decidualization were excluded from this study.
Statistical analysis
The results are expressed as means + SEM. Statistical analysis of quantitative data was conducted by the Student's t-test or one-way analysis of variance for significance. Data that did not conform to the normal distribution were analyzed using the rank sum test for significance. P , 0.05 was regarded as significant.
Results
RU486 administration activates NF-kB in vivo
Representative morphological changes in the endometrium at different time points after mifepristone administration have been reported previously (Xu et al., 2007) . In brief, the endometrium underwent extensive decidualization at 0 h, and then the boundary between the basal and functional layers became clear from 8 to 12 h. At 16 h, a large area of the stroma exhibited necrosis with hemorrhage. Most of the decidualized tissue had sloughed into the uterine lumen at 24 h. Immunohistochemical analysis was performed to verify the NF-kB translocation and to determine the level of activated NF-kB signals. As shown in Fig. 2A , at 0 h at the time of RU486 administration (the endometrium had undergone extensive decidualization at this stage), NF-kB p65 and p50 were mostly located in the cytoplasm of the subepithelial stromal cells and were low in abundance. Weak staining was observed in the luminal and glandular epithelia. When the breakdown changes of the endometrium progressed from 12 to 16 h, p65 was distinctly translocated from the cytoplasm to the nucleus in the stromal and glandular epithelial cells, whereas less p50 did so. Once the decidual zone had broken down, large numbers of p65 positive cells were also identified within areas of tissue breakdown, whereas less p50 positive cells were identified in the same area. However, NF-kB p50 was often expressed in the invading leukocytes in the myometrium in all stages. Meanwhile, the protein levels of NF-kB p65 and p50 from uterine tissues were analyzed to assess their translocation from cytoplasm to nucleus. By western blotting, we observed that RU486 induced a remarkable increase in the expression of nuclear p65 and a gradual increase in p50, both of which peaked at 12 h. In a parallel comparison, the cytoplasmic levels of NF-kB p65 and p50 decreased within 24 h. RU486 also caused a rapid increase in cytosolic phospho-IkB (Ser32) protein levels that was peaked at 16 h (Fig. 2B) .
To further explore the complex signaling network activated after RU486 administration in the model, real-time PCR was performed to determine the mRNA levels of the NF-kB inducing kinase (NIK), mitogen/Erk-activated protein kinase kinase 1 (MEKK-1), IkB kinase a (IKKa), IkB kinase b (IKKb) and inhibitor of kBa (IkBa), which are all intermediates in the NF-kB signaling pathway. As seen in Fig. 2C , the IkBa mRNA levels were significantly greater at 12 h, compared with those from all other stages of the tissue shedding process in the model. NIK and IKKb mRNA levels increased at 8 h compared with those in other stages. However, the MEKK-1 and IKKa mRNA levels were not changed throughout the observation period. These results suggested that activation of NF-kB may be related to the function of two kinases (NIK and IKKb) after RU486 administration in mouse menstruation-like model.
WP induces MMP9 expression
In this study, we examined the effects of RU486 on the expression of MMP9. There was a significant increase in MMP9 mRNA expression with the maximal level ( 50-fold) at 16 h, followed by a decrease at 24 h during the breakdown period (Fig. 3A) . The change of total protein levels of MMP9 followed the same patterns as its mRNA levels (Fig. 3B) . In addition, gelatinolytic activity of MMP9 was assessed by zymography (Fig. 3C ). There was an apparent increase in this activity within 16 h (the functional zone of stroma began degeneration with hemorrhage in this stage) and a decrease at 24 h, which corresponded with the MMP9 mRNA expression. Immunohistochemically, MMP9-immunopositive cells were present in the cross sections of decidualized uterine horns all the time after RU486 treatment (Fig. 3D) . The completely decidualized zone displayed minor staining for MMP9 at 0 h (48 h after oil infusion). At 12 h when little breakdown of tissues had taken place, weak staining was detected in the decidualized zone. At 16 h when the drastic breakdown activity was observed, MMP9-positive cells were located in the stroma in both the basal zone and the decidualized zone, as well as in the extracellular matrix (ECM) across the border of dissociating tissue. Meanwhile, there was weak staining of MMP9 in the decidualized zone, and no or little staining in the glandular epithelia and myometrium. Taken together, these results demonstrated a dynamic change in expressions and activities in stroma after RU486, and indicated that MMP9 may take part in the tissue breakdown. In addition, immunoreactive MMP9 and NF-kB exhibited similar patterns of distribution in the decidual stromal at the time that maximum breakdown activity was observed (16 h) ( Fig. 2A and 3D) . The temporally and spatially coordinated localization of the two proteins in vivo led us to hypothesize that NF-kBs may regulate the expression of MMP9 during tissue breakdown. The levels of p50, p65 and phospho-IkB in cytoplasmic and nuclear extracts after RU486 administration were determined by a western blot. Nuc, nuclear extracts; Cyto, cytoplasmic extracts, n ¼ 3 for each group; (C) Real-time PCR with SYBR Green was used to determine levels of the intermediates NIK, MEKK-1, IKK-a, IKK-b and IKB-a in the NF-kB signaling pathway. Each mRNA level was normalized relative to the abundance of b-actin. *P , 0.05; **P , 0.01. Data are the mean + SEM from three separate experiments.
NF-kB binding to the promoter of MMP9 contributes to its expression
To investigate whether NF-kB p65 directly binds to the promoter of MMP9, the ChIP assay was conducted with nuclear extracts isolated from uteri at different time points of RU486-induced tissue breakdown. Real-time PCR was used to amplify an 229-bp genomic sequence from chromatin complexes immunoprecipitated with a p65 antibody. As seen in Fig. 4 , RU486 stimulated recruitment of p65 to a response element of the MMP9 gene promoter with greater amounts of p65 at 12 h than any other time point after RU486 administration. Therefore, the ChIP assay confirmed that a functional interaction between NF-kB and the MMP9 promoter element occurred following RU486 treatment.
PDTC treatment partially suppresses the breakdown of endometrium and the expression of MMP9 in vivo
To further understand the role of the NF-kB-MMP9 interaction in the process of endometrial tissue breakdown, we also determined the effects of blocking NF-kB by PDTC, a well-known NF-kB inhibitor, on the RU486-induced tissue breakdown in mouse menstruation-like model. First, 8 of 12 mice inspected in the control group were bleeding by 12 h after RU486 administration, while none were bleeding in the PDTC treatment group. Second, the uterine horns in the control group were dark red in color, which indicated drastic tissue breakdown, while those in the PDTC treatment group were pink (Fig. 5A) . Histologically, the ratio of the average breakdown area in the control group was 90%, while it was 45% in the PDTC treatment group (Fig. 5B) . However, there were variations in the response to PDTC treatment between animals and among different parts of the uterine horn in each affected animal. PDTC treatment suppressed NF-kB-mediated transcription of the MMP9 gene by 2-fold when compared with the vehicle controls (Fig. 5C ). These results showed that treatment with PDTC partly inhibited tissue breakdown and NF-kB-induced MMP9 expression in the model.
Activation of the NF-kB response pathway increases MMP9 expression in stromal cells
As seen in the sections of Fig. 3D , the immunohistochemical findings implied that MMP9 activity in the tissue breakdown mainly took effect in the stromal compartment of the endometrium. To further clarify the role of NF-kB-mediated MMP9 regulation in the stromal cells, we first mimicked WP conditions in decidual stromal cells from mice in vitro. The patterns of NF-kB translocation from the cytoplasm to the nucleus in the stromal cells were monitored using fluorescence microscopy. As expected, at 16 h after treatment with RU486, both p65 and p50 translocated into the nucleus, while at 0 h they were sequestered in the cytoplasm (Fig. 6A) . Meanwhile, MMP9 mRNA levels were significantly greater at 16 h compared with stromal cells from all other time points (Fig. 6B) . Furthermore, MG-132 (NF-kB inhibitor) treatment caused a reduction in expression of MMP9 within 24 h (Fig. 6B) . We further worked on the primary human endometrial stromal cells by mimicking the process of menstruation in vitro. In Fig. 7A , human endometrial stromal cells cultured without MPA + E 2 remained a fibroblastlike shape throughout the culture period. In the presence of MPA + E 2 , these spindle-shaped stromal cells were transformed into large polygonal cells (Fig. 7B) , which appeared as decidualization-related morphological changes (Irwin et al., 1989) . The concentration of prolactin in culture media was increased in MPA + E 2 group compared with that of controls and peaked at Day 9 of culture (Fig. 7C) . The mRNA levels of MMP9 were greater at Day 4 of culture with RU486 treatment compared with Days 0 and 2. MG-132 treatment also caused a decrease in the expression of MMP9 within 6 days in the stromal cells (Fig. 7D) . In the decidual stromal cells, we also found that the NF-kB signals and expression of MMP9 were well-correlated.
Discussion
In the present study, we demonstrated that the NF-kB signaling pathway was involved in the breakdown process of endometrial tissues and that RU486 caused a rapid induction of MMP9 expression via NF-kB in the mouse menstruation-like model. The role of the NF-kB pathway in the process was validated by administration of an NF-kB inhibitor PDTC in vivo, which led to a reduction in the degree of tissue breakdown. In addition, expression and proteolytic activity of MMP9, a major effector of tissue breakdown, were synchronized with the activation of NF-kB. The direct control of MMP9 expression by NF-kB was supported by a ChIP assay demonstrating the binding of NF-kB to the promoter region of MMP9 gene after administration with RU486.
The activity of NF-kB is primarily regulated by interaction with inhibitory IkBa proteins in most species. In resting cells, NF-kB dimers are bound to inhibitory IkBa, which sequester the dimers by forming a complex in the cytoplasm. Upon stimulation, phosphorylation of IkBa results in its ubiquitination and subsequent degradation, which then liberates the NF-kB dimer and allows its translocation into the nucleus to regulate target genes. In this study, although the protein levels band of p-IkBa were low at 8 h (Fig. 2B) , it was increased reliably compared with that at 0 h after RU486 administration and was obviously increased at 12 and 16 h. Meanwhile, NF-kB p65 was distinctly translocated from the cytoplasm to the nucleus. In addition, p65 binding to the promoter of MMP9 further increased its expression in the same condition. These results suggested that NF-kB was activated after administration of RU486. Because menstrual breakdown was initiated by WP through the receptor antagonist RU486 in this study, the activation of NF-kB resulted from reversal of the The area that exhibited breakdown was reduced by 50% as determined by calculating the ratio of breakdown area of endometrium to total decidual area. *P , 0.05 (quantitative data were analyzed by the rank sum test for significance). (C) Total RNA from uterine tissues was isolated, and MMP9 expression was analyzed using real-time PCR *P , 0.05. Data are the mean + SEM from three separate experiments.
suppressive effects of progesterone. Previous studies have demonstrated that there are different NF-kB dimers (heterodimers or homodimers) in various cell types (Ahmad et al., 1995; Marui et al., 2005) . From the results of immunohistochemistry and western blotting in this study, a significant amount of p65 translocated to the nucleus, while less p50 did so after RU486 administration. Thus, other NF-kB dimers such as p65/p65, besides the classic p50/p65, may exist in the stromal cells of the endometrium.
Interestingly, IkB mRNA expression increased within 12 h after RU486 treatment. Progesterone can increase both mRNA and protein levels of IkBa via the PGR to inhibit NF-kB in breast cancer cells (Hardy et al., 2008) . However, RU486 antagonized PGR activity; thus, the increased mRNA of IkBa was activated by NF-kB (negative feedback loop) (Sun et al., 1993) .
According to a previous report of human menstruation, in the perimenstrual period, up-regulation of IkBa mRNA was observed, the expression of IKK-b was maximal but the difference was not significant compared with proliferative and secretory phases, and no change of NIK or MEKK-1 was found . While in our study, NIK and IKKb mRNA levels increased at 8 h, whereas MEKK-1 and IKKa mRNA levels were not changed by administration of RU486. This suggests that activated NF-kB may be related with two kinases (NIK and IKKb) after RU486 administration in the model and differ from human in upstream regulation of NF-kB activation. Stimulus-induced phosphorylation of IkBa proteins is initiated by the IKK complex including IKKa and IKKb, which can be activated by NIK and MEKK-1 (Lee et al., 1998; Nakano et al., 1998) . Recent studies have suggested a far more complicated regulatory network and mechanisms. We do not know how to explain the species difference and this issue remains to be further explored.
To verify the role of NF-kB in endometrial breakdown, we examined the effects of blocking NF-kB on the tissue breakdown using PDTC in vivo. Administration of PDTC partially reversed the breakdown of the decidualized endometrium after RU486 treatment. In the affected animals, there was an average of 50% decrease of area that exhibited breakdown. These results suggested that NF-kBs participated in the process of tissue breakdown after RU486 treatment. Partially blocking NF-kB by PDTC treatment may be attributed to several reasons. First, potential compensating mechanisms by other signaling pathways such as the AP1 pathway, which also mediates inflammatory immune responses, could have come into effect and bypassed the NF-kB pathway (Schonthaler et al., 2011) . Furthermore, administration with PDTC not only blocks NF-kB but also promotes DNA binding activity of AP1 and cAMP-response element binding protein (Liu et al., 1999) , and the net effects of PDTC on downstream cytokines may be greatly reduced in vivo. Thus, NF-kB may not be the only pathway controlling PGR downstream events. Second, MMP9 is recognized as an important component in the process of cycle changes, including menstrual cycle and implantation. Although we show that NF-kB can directly regulate the expression of MMP9 participating in the process of tissue breakdown, other cytokines can also regulate the expression of MMP9. LEFTY-A, as an important regulator of endometrial ECM breakdown, also influences the expression of MMP9 (Cornet et al., 2005) . Transforming growth factor-b has been shown to significantly increase MMP9 mRNA expression in the endometrial stroma during implantation and decidualization (Bany et al., 2000) . The relationship between NF-kB and other signaling pathways in menstrual tissue breakdown deserves further exploration.
Several laboratories have confirmed that the markedly increased expression of MMP9 in the human endometrium is associated with WP In the model, RU486 increased the expression of MMP9. At 16 h after the initiation of RU486 treatment, the time when the endometrium had drastically deteriorated, MMP9 expression was at the highest level, while immunoreactive MMP9 was detected in stromal cells in all stages. However, high levels of MMP9 protein were identified in the stroma around the area where the completely decidualized stroma broke down, especially at the border of the deteriorated tissue and basal endometrium at 16 h. The tissues in these zones were expected to slough and bleed during menstruation. Furthermore, MMP9 demonstrated strong proteolytic activity by zymography at this time (16 h). Therefore, the tissue breakdown was temporally and spatially correlated with the expression and activity of MMP9 in the stromal cells, suggesting that MMP9 in the stromal cells actively participated in the tissue breakdown. In addition, the basal zone that were positively stained for MMP9 does not show breakdown in all the phases, and the signals may be the immunoreactivity for the proenzyme form of MMP9. Because MMP9 is synthesized and secreted in the form of proenzyme that is activated by removing the propeptide. MMP9 has been associated with populations of eosinophils, neutrophils, mast cells and macrophages in the endometrial tissues at menstruation (Jeziorska et al., 1996) . The present study provided strong evidence supporting a role for MMP9 in mouse and human decidual stromal cells during breakdown. We confirmed that RU486 activates NF-kB to further regulate expression of MMP9 in stromal cells, which are involved in tissue breakdown, and highlighted the likelihood that this regulatory pattern exists in multiple processes of human reproduction such as menstruation, abortion and parturition. These results are consistent with a previous study suggesting that the initiation of shedding and bleeding of the endometrium is directly triggered by stromal cells . However, the relative contribution of MMP9 from various cells in menstruation remains to be determined.
One of the advantages of the mouse menstruation model is that it allows us to determine the time course of endometrial breakdown and regeneration during remodeling of the endometrium. It would therefore facilitate the dissection of the molecular program controlling this process after administration with RU486. In histological observations, degradation of decidual tissue was most drastic at 16 h, and the tissue was completely shed by 24 h after treatment (Brasted et al., 2003; Xu et al., 2007) . Our observations indicated that activation of NF-kB reached a peak at 12 h. This period would allow stimulation of downstream target genes controlled by NF-kB. Another study in our laboratory showed that adding back progesterone can delay or inhibit the endometrial breakdown within 12 h after WP (data not shown). Similarly, a previous study that tested the effect of adding back progesterone during withdrawal identified two phases of menstrual breakdown: a reversible and irreversible phase of the progesterone downstream effects (Slayden et al., 2006) . Therefore, it also suggested that the NF-kB pathway may be closely related with endometrial breakdown.
Based on our findings and previous studies, we propose that menstruation occurs through a cascade of endometrial events. First, the decline of progesterone in the sensitive phase is a key initiating event. Responded to the falling of progesterone due to administration with RU486, NF-kB activation is initiated by IkBa phosphorylation and then activates target genes, including those of cytokines, inflammatory factors and MMPs in the endometrial stromal cells. The increased production of these gene products consequently induces invasion of leukocytes, stimulating secretion of even more cytokines and inflammatory factors in a paracrine manner. Alternatively, various types of leukocytes may also secrete MMP9 and other lytic enzymes, which can facilitate endometrial tissue breakdown and bleeding. 
